Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Return on Capital Employed (2021 - 2025)

Treace Medical Concepts (TMCI) has disclosed Return on Capital Employed for 5 consecutive years, with 0.33% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed fell 2.0% year-over-year to 0.33%, compared with a TTM value of 0.33% through Dec 2025, down 2.0%, and an annual FY2025 reading of 0.31%, down 3.0% over the prior year.
  • Return on Capital Employed was 0.33% for Q4 2025 at Treace Medical Concepts, down from 0.3% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.02% in Q1 2021 and bottomed at 0.34% in Q3 2024.
  • Average Return on Capital Employed over 5 years is 0.23%, with a median of 0.26% recorded in 2022.
  • The sharpest move saw Return on Capital Employed dropped -22bps in 2022, then increased 5bps in 2023.
  • Year by year, Return on Capital Employed stood at 0.14% in 2021, then plummeted by -100bps to 0.27% in 2022, then grew by 6bps to 0.26% in 2023, then dropped by -21bps to 0.31% in 2024, then decreased by -7bps to 0.33% in 2025.
  • Business Quant data shows Return on Capital Employed for TMCI at 0.33% in Q4 2025, 0.3% in Q3 2025, and 0.29% in Q2 2025.